Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation
Authors:
- M Hasib SidiqiMSM Hasib Sidiqi
- Mohammed A. AljamaMAMohammed A. Aljama
- Eli MuchtarEMEli Muchtar
- Francis K. BuadiFBFrancis K. Buadi
- Rahma WarsameRWRahma Warsame
- Martha Q. LacyMLMartha Q. Lacy
- Angela DispenzieriADAngela Dispenzieri
- David DingliDavid Dingli
- Nelson LeungNLNelson Leung
- Wilson I. GonsalvesWGWilson I. Gonsalves
- Shaji K. KumarSKShaji K. Kumar
- Prashant KapoorPKPrashant Kapoor
Open Access
- 3 April 2018
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 2 (7) , 769-776
Abstract
Key Points: λ Light chain AL amyloidosis is associated with a shorter PFS and OS compared with κ. Light chain type predicts likelihood of organ involvement in AL amyloidosis.Keywords
This publication has 36 references indexed in Scilit:
- New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival OutcomesJournal of Clinical Oncology, 2012
- Lenalidomide, cyclophosphamide, and dexamethasone (CRd) for light-chain amyloidosis: long-term results from a phase 2 trialBlood, 2012
- Amyloidosis: Pathogenesis and New Therapeutic OptionsJournal of Clinical Oncology, 2011
- Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical featuresBlood, 2010
- Autologous stem cell transplant for immunoglobulin light chain amyloidosis: a status reportLeukemia & Lymphoma, 2010
- Overestimation of Serum κ Free Light Chain Concentration by ImmunonephelometryClinical Chemistry, 2010
- High-Dose Melphalan versus Melphalan plus Dexamethasone for AL AmyloidosisNew England Journal of Medicine, 2007
- Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and AmyloidosisAmerican Journal of Hematology, 2005
- Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic AmyloidosisJournal of Clinical Oncology, 2004
- The tropism of organ involvement in primary systemic amyloidosis: contributions of Ig VL germ line gene use and clonal plasma cell burdenBlood, 2001